GE HealthCare Technologies holds the cleaner structural position, with the lead spread across valuation and profitability. Thermo Fisher Scientific still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward Thermo Fisher Scientific, which does not confirm the structural lead. That leaves a split case: the structural lead stays with GE HealthCare Technologies, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.
This is not just a one-metric split: both valuation and profitability materially support the lead. The overall score gap is 11 points in favour of GE HealthCare Technologies Inc..
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.
The match is driven mainly by margin consistency and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
The two profiles are relatively close, but the price setup still leans toward GE HealthCare Technologies Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where GEHC and TMO each sit in their own 3.7-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The multiple-based pricing edge comes from a forward P/E that is 7.8 turns lower.
A meaningful counterforce remains in growth, which keeps the comparison from looking completely one-sided.
The lead is built on both valuation and profitability — though growth still provides a counterweight.
Break down the GEHC vs TMO comparison across all dimensions with the full interactive tool.
Explore how GEHC and TMO each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.